We are delighted to announce that we have successfully reached our recruitment target.

Twenty-four clinicians and laboratory technicians have enrolled in a bespoke training programme designed to strengthen the diagnosis and treatment of deadly fungal diseases. With infections soaring gl...

Introduction Invasive bacterial infections, particularly those caused by the ESKAPE group, account for a substantial proportion of neonatal deaths in low- and middle-income countries, yet the contribu...

<em>C. auris</em> Colonization Screening to Clinical Case

Background: Klebsiella pneumoniae causes ~20% of sepsis in neonates, with ~40% crude mortality. A vaccine administered to pregnant women, protecting against 70% of K. pneumoniae infections, could aver...

Are we ready to fight off a new world of infections?

The WHO, which faces an extraordinary financial crunch in the wake of the U.S. withdrawal from the agency, has dramatically trimmed its top management.

Abstract. Navigating antibiotics at the end of life is a challenge for infectious disease (ID) physicians who remain deeply committed to providing patient-

New and minimally invasive tools to aid the diagnosis of invasive fungal diseases (IFD) are urgently needed as the immunocompromised population at highest risk increases. Advancements in molecular technology have rendered new diagnostics more readily available for clinical use.

Fungi can keep us healthy or cause disease. As climate change drives fungi to adapt, learn how we can harness the benefits and tackle the threats.

People with advanced HIV disease (AHD; defined among adults as a CD4 cell count &lt;200 cells/µL or a World Health Organization [WHO] stage 3 or 4 clinical event) are at increased risk of hospitalizat...

The US has abruptly suspended almost all foreign development assistance globally, including the President’s Emergency Plan for AIDS Relief (PEPFAR) and National Institutes of Health (NIH) research gra...

Three years in the making, the accord aims to increase equity and avoid errors of the COVID-19 pandemic

Critical community initiatives that provide testing, food and support and HIV vaccine research have been dismantled.

Advanced HIV disease is a major cause of morbidity and mortality in people with HIV (PWH) in Latin America. It remains unclear whether mortality differ between people with advanced HIV who are treatment-naïve (TN) and those who have discontinued antiretroviral treatment (TD).

A new analysis raises concerns over the stoppage of funding for this long-standing program, which could have major impacts on global public health for years to come.

Individuals hospitalized with HIV-related complications face high post-discharge mortality and morbidity, particularly in resource-limited settings.

Agency moves to terminate nearly 1000 awards, including programs involving “DEI”

Professor Joe Jarvis, a recognized leader in global health has been appointed as Honorary member with the University of Exeter and the MRC Centre for Medical Mycology. His expertise and established ne...

Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV vaccine trial and other HIV-related research in Africa.

We have to go toe-to-toe with this administration and resist its attacks on public health.

President Trump directed officials to prioritize the resettlement of Afrikaners in South Africa through the U.S. refugee program, which he suspended on his first day in office.

Dismantling of USAID could disrupt clinical trials and wipe away U.S. “soft power” in developing countries, scientists warn